Bard Logo

Investor Relations

Webcast ImageWebcast
Q3 2014 C. R. Bard, Inc. Earnings Conference Call (Replay)
10/22/14 at 5:00 p.m. ET
Q3 2014 C. R. Bard, Inc. Earnings Conference Call
Wednesday, October 22, 2014 5:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
BCR (Common Stock)
ExchangeNYSE (US Dollar)
Price$156.97
Change (%) Stock is Up 2.74 (1.78%)
Volume759,018
Data as of 10/24/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Featured Reports
Download Documentation2014 Proxy Statement
Download Documentation2013 Annual Report
Related Links
Corporate Governance
Contact the Bard Board of Directors
Recent NewsMore >>
DateTitle 
10/22/14Bard Announces Third Quarter Results
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 22, 2014-- C. R. Bard, Inc. (NYSE:BCR) today reported 2014 third quarter financial results. Third quarter 2014 net sales were $830.0 million, an increase of 9 percent over the prior-year period on both an as reported and constant currency basis. For the third quarter 2014, net sales in the U.S. were $565.4 million, an increase of 13 percent over the prior-year period. Net sales outside the U.S. were... 
Printer Friendly Version
10/10/14The Lutonix® 035 Drug Coated Balloon is the First and Only FDA-Approved DCB Available in the U.S. for the Treatment of Femoropopliteal Occlusive Disease
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 10, 2014-- C. R. Bard, Inc. (NYSE: BCR) today announced the U.S. Food and Drug Administration (FDA) approval of the Lutonix® 035 Drug Coated Balloon (DCB) Catheter for percutaneous transluminal angioplasty (PTA), after pre-dilatation, for the treatment of de novo or restenotic lesions up to 150mm in length in native vascular disease of the superficial femoral or popliteal arteries with reference vessel diameters o... 
Printer Friendly Version
10/08/14Bard Declares Quarterly Dividend
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 8, 2014-- The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 22 cents per share on Bard's common stock. The current indicated annual dividend rate is 88 cents per share. The dividend is payable on October 31, 2014 to shareholders of record at the close of business on October 20, 2014. C. R. Bard, Inc. (www.crbard.com), headquartered in Murray Hill, N... 
Printer Friendly Version
10/01/14Bard to Host Earnings Conference Call on October 22, 2014
MURRAY HILL, N.J.--(BUSINESS WIRE)--Oct. 1, 2014-- C. R. Bard, Inc. (NYSE:BCR) today announced that it will host a conference call on Wednesday, October 22, 2014 at 5:00 PM EDT, to discuss the company’s third quarter 2014 operating results, and to provide financial guidance for the fourth quarter of 2014. Bard is scheduled to issue an earnings press release after the market closes on October 22, 2014. A live audio webcast of Bard's investo... 
Printer Friendly Version
Selected SEC Filings
Filing DateForm
10/23/1410-Q Download SEC Filing to Adobe PDF Download XBRL Content
07/25/1410-Q Download SEC Filing to Adobe PDF Download XBRL Content
04/23/1410-Q Download SEC Filing to Adobe PDF Download XBRL Content
02/19/1410-K Download SEC Filing to Adobe PDF Download XBRL Content
10/24/1310-Q Download SEC Filing to Adobe PDF Download XBRL Content
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever C. R. Bard, Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.